ENTRY       hsa04152                    Pathway
NAME        AMPK signaling pathway - Homo sapiens (human)
DESCRIPTION AMP-activated protein kinase (AMPK) is a serine threonine kinase that is highly conserved through evolution. AMPK system acts as a sensor of cellular energy status. It is activated by increases in the cellular AMP:ATP ratio caused by metabolic stresses that either interfere with ATP production (eg, deprivation for glucose or oxygen) or that accelerate ATP consumption (eg, muscle contraction). Several upstream kinases, including liver kinase B1 (LKB1), calcium/calmodulin kinase kinase-beta (CaMKK beta), and TGF-beta-activated kinase-1 (TAK-1), can activate AMPK by phosphorylating a threonine residue on its catalytic alpha-subunit. Once activated, AMPK leads to a concomitant inhibition of energy-consuming biosynthetic pathways, such as protein, fatty acid and glycogen synthesis, and activation of ATP-producing catabolic pathways, such as fatty acid oxidation and glycolysis.
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04152  AMPK signaling pathway
DBLINKS     BSID: 989139
            GO: 2000479
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            6794  STK11; serine/threonine kinase 11 [KO:K07298]
            51719  CAB39; calcium binding protein 39 [KO:K08272]
            81617  CAB39L; calcium binding protein 39 like [KO:K08272]
            92335  STRADA; STE20-related kinase adaptor alpha [KO:K08271]
            55437  STRADB; STE20-related kinase adaptor beta [KO:K17532]
            3952  LEP; leptin [KO:K05424]
            3953  LEPR; leptin receptor [KO:K05062]
            84254  CAMKK1; calcium/calmodulin-dependent protein kinase kinase 1 [KO:K07359] [EC:2.7.11.17]
            10645  CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2 [KO:K07359] [EC:2.7.11.17]
            148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]
            9370  ADIPOQ; adiponectin, C1Q and collagen domain containing [KO:K07296]
            51094  ADIPOR1; adiponectin receptor 1 [KO:K07297]
            79602  ADIPOR2; adiponectin receptor 2 [KO:K07297]
            5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.11]
            5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.11]
            5564  PRKAB1; protein kinase AMP-activated non-catalytic subunit beta 1 [KO:K07199]
            5565  PRKAB2; protein kinase AMP-activated non-catalytic subunit beta 2 [KO:K07199]
            5571  PRKAG1; protein kinase AMP-activated non-catalytic subunit gamma 1 [KO:K07200]
            53632  PRKAG3; protein kinase AMP-activated non-catalytic subunit gamma 3 [KO:K07200]
            51422  PRKAG2; protein kinase AMP-activated non-catalytic subunit gamma 2 [KO:K07200]
            5207  PFKFB1; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 [KO:K19028] [EC:3.1.3.46 2.7.1.105]
            5208  PFKFB2; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 [KO:K19029] [EC:3.1.3.46 2.7.1.105]
            5209  PFKFB3; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 [KO:K01103] [EC:3.1.3.46 2.7.1.105]
            5210  PFKFB4; 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 [KO:K19030] [EC:3.1.3.46 2.7.1.105]
            2203  FBP1; fructose-bisphosphatase 1 [KO:K03841] [EC:3.1.3.11]
            8789  FBP2; fructose-bisphosphatase 2 [KO:K03841] [EC:3.1.3.11]
            5213  PFKM; phosphofructokinase, muscle [KO:K00850] [EC:2.7.1.11]
            5214  PFKP; phosphofructokinase, platelet [KO:K00850] [EC:2.7.1.11]
            5211  PFKL; phosphofructokinase, liver type [KO:K00850] [EC:2.7.1.11]
            3172  HNF4A; hepatocyte nuclear factor 4 alpha [KO:K07292]
            2538  G6PC; glucose-6-phosphatase catalytic subunit [KO:K01084] [EC:3.1.3.9]
            57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]
            92579  G6PC3; glucose 6 phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]
            5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]
            5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]
            200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
            90993  CREB3L1; cAMP responsive element binding protein 3-like 1 [KO:K09048]
            64764  CREB3L2; cAMP responsive element binding protein 3-like 2 [KO:K09048]
            84699  CREB3L3; cAMP responsive element binding protein 3-like 3 [KO:K09048]
            148327  CREB3L4; cAMP responsive element binding protein 3-like 4 [KO:K09048]
            9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
            10891  PPARGC1A; PPARG coactivator 1 alpha [KO:K07202]
            1994  ELAVL1; ELAV like RNA binding protein 1 [KO:K13088]
            595  CCND1; cyclin D1 [KO:K04503]
            890  CCNA2; cyclin A2 [KO:K06627]
            8900  CCNA1; cyclin A1 [KO:K06627]
            29904  EEF2K; eukaryotic elongation factor 2 kinase [KO:K08292] [EC:2.7.11.20]
            101930123  eukaryotic elongation factor 2 kinase; K08292 elongation factor 2 kinase [EC:2.7.11.20] [KO:K08292] [EC:2.7.11.20]
            1938  EEF2; eukaryotic translation elongation factor 2 [KO:K03234]
            2308  FOXO1; forkhead box O1 [KO:K07201]
            2309  FOXO3; forkhead box O3 [KO:K09408]
            23411  SIRT1; sirtuin 1 [KO:K11411] [EC:3.5.1.-]
            6517  SLC2A4; solute carrier family 2 member 4 [KO:K07191]
            2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]
            2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]
            3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]
            3156  HMGCR; 3-hydroxy-3-methylglutaryl-CoA reductase [KO:K00021] [EC:1.1.1.34]
            6720  SREBF1; sterol regulatory element binding transcription factor 1 [KO:K07197]
            2194  FASN; fatty acid synthase [KO:K00665] [EC:2.3.1.85]
            31  ACACA; acetyl-CoA carboxylase alpha [KO:K11262] [EC:6.3.4.14 6.4.1.2]
            6319  SCD; stearoyl-CoA desaturase (delta-9-desaturase) [KO:K00507] [EC:1.14.19.1]
            79966  SCD5; stearoyl-CoA desaturase 5 [KO:K00507] [EC:1.14.19.1]
            23417  MLYCD; malonyl-CoA decarboxylase [KO:K01578] [EC:4.1.1.9]
            1374  CPT1A; carnitine palmitoyltransferase 1A [KO:K08765] [EC:2.3.1.21]
            1375  CPT1B; carnitine palmitoyltransferase 1B [KO:K19523] [EC:2.3.1.21]
            126129  CPT1C; carnitine palmitoyltransferase 1C [KO:K19524] [EC:2.3.1.21]
            5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]
            5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]
            5519  PPP2R1B; protein phosphatase 2 regulatory subunit A, beta [KO:K03456]
            5518  PPP2R1A; protein phosphatase 2 regulatory subunit A, alpha [KO:K03456]
            5520  PPP2R2A; protein phosphatase 2 regulatory subunit B, alpha [KO:K04354]
            5521  PPP2R2B; protein phosphatase 2 regulatory subunit B, beta [KO:K04354]
            5522  PPP2R2C; protein phosphatase 2 regulatory subunit B, gamma [KO:K04354]
            55844  PPP2R2D; protein phosphatase 2 regulatory subunit B, delta [KO:K04354]
            28227  PPP2R3B; protein phosphatase 2 regulatory subunit B'', beta [KO:K11583]
            55012  PPP2R3C; protein phosphatase 2 regulatory subunit B'', gamma [KO:K11583]
            5523  PPP2R3A; protein phosphatase 2 regulatory subunit B'', alpha [KO:K11583]
            5526  PPP2R5B; protein phosphatase 2 regulatory subunit B', beta [KO:K11584]
            5527  PPP2R5C; protein phosphatase 2 regulatory subunit B', gamma [KO:K11584]
            5528  PPP2R5D; protein phosphatase 2 regulatory subunit B', delta [KO:K11584]
            5529  PPP2R5E; protein phosphatase 2 regulatory subunit B', epsilon [KO:K11584]
            5525  PPP2R5A; protein phosphatase 2 regulatory subunit B', alpha [KO:K11584]
            23216  TBC1D1; TBC1 domain family member 1 [KO:K18341]
            5862  RAB2A; RAB2A, member RAS oncogene family [KO:K07877]
            4218  RAB8A; RAB8A, member RAS oncogene family [KO:K07901]
            10890  RAB10; RAB10, member RAS oncogene family [KO:K07903]
            9230  RAB11B; RAB11B, member RAS oncogene family [KO:K07905]
            51552  RAB14; RAB14, member RAS oncogene family [KO:K07881]
            1080  CFTR; cystic fibrosis transmembrane conductance regulator [KO:K05031] [EC:3.6.3.49]
            948  CD36; CD36 molecule [KO:K06259]
            3479  IGF1; insulin like growth factor 1 [KO:K05459]
            3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
            3630  INS; insulin [KO:K04526]
            3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
            3667  IRS1; insulin receptor substrate 1 [KO:K16172]
            8660  IRS2; insulin receptor substrate 2 [KO:K07187]
            8471  IRS4; insulin receptor substrate 4 [KO:K17446]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            7249  TSC2; tuberous sclerosis 2 [KO:K07207]
            7248  TSC1; tuberous sclerosis 1 [KO:K07206]
            6009  RHEB; Ras homolog enriched in brain [KO:K07208]
            2475  MTOR; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
            57521  RPTOR; regulatory associated protein of MTOR, complex 1 [KO:K07204]
            84335  AKT1S1; AKT1 substrate 1 (proline rich) [KO:K16184]
            6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
            6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
            1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
            5468  PPARG; peroxisome proliferator activated receptor gamma [KO:K08530]
            32  ACACB; acetyl-CoA carboxylase beta [KO:K01946] [EC:6.3.4.14 6.4.1.2]
            8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K08269] [EC:2.7.11.1]
COMPOUND    C00003  NAD+
            C00008  ADP
            C00020  AMP
            C00022  Pyruvate
            C00024  Acetyl-CoA
            C00031  D-Glucose
            C00040  Acyl-CoA
            C00076  Calcium cation
            C00083  Malonyl-CoA
            C00085  D-Fructose 6-phosphate
            C00162  Fatty acid
            C00354  D-Fructose 1,6-bisphosphate
            C00389  Quercetin
            C00665  beta-D-Fructose 2,6-bisphosphate
            C00668  alpha-D-Glucose 6-phosphate
            C00698  Cl-
            C00757  Berberine
            C01172  beta-D-Glucose 6-phosphate
            C04677  1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C07151  Metformin
            C09731  Epigallocatechin 3-gallate
            D08351  Phenformin (BAN)
REFERENCE   PMID:19584320
  AUTHORS   Steinberg GR, Kemp BE
  TITLE     AMPK in Health and Disease.
  JOURNAL   Physiol Rev 89:1025-78 (2009)
REFERENCE   PMID:15509864
  AUTHORS   Hardie DG.
  TITLE     The AMP-activated protein kinase pathway--new players upstream and downstream.
  JOURNAL   J Cell Sci 117:5479-87 (2004)
REFERENCE   PMID:23747347
  AUTHORS   Russo GL, Russo M, Ungaro P
  TITLE     AMP-activated protein kinase: a target for old drugs against diabetes and cancer.
  JOURNAL   Biochem Pharmacol 86:339-50 (2013)
REFERENCE   PMID:19393004
  AUTHORS   Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S
  TITLE     AMPK in the brain: its roles in energy balance and neuroprotection.
  JOURNAL   J Neurochem 109 Suppl 1:17-23 (2009)
REFERENCE   PMID:20010958
  AUTHORS   Li J, McCullough LD
  TITLE     Effects of AMP-activated protein kinase in cerebral ischemia.
  JOURNAL   J Cereb Blood Flow Metab 30:480-92 (2010)
REFERENCE   PMID:22700795
  AUTHORS   Sanchez AM, Candau RB, Csibi A, Pagano AF, Raibon A, Bernardi H
  TITLE     The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.
  JOURNAL   Am J Physiol Cell Physiol 303:C475-85 (2012)
REFERENCE   PMID:16644802
  AUTHORS   Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F
  TITLE     Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.
  JOURNAL   J Physiol 574:41-53 (2006)
REFERENCE   PMID:19629071
  AUTHORS   Shackelford DB, Shaw RJ
  TITLE     The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.
  JOURNAL   Nat Rev Cancer 9:563-75 (2009)
REFERENCE   PMID:22885100
  AUTHORS   Chung JH, Manganiello V, Dyck JR
  TITLE     Resveratrol as a calorie restriction mimetic: therapeutic implications.
  JOURNAL   Trends Cell Biol 22:546-54 (2012)
REFERENCE   PMID:20357764
  AUTHORS   Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T
  TITLE     Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.
  JOURNAL   Nature 464:1313-9 (2010)
REFERENCE   PMID:17307971
  AUTHORS   Towler MC, Hardie DG
  TITLE     AMP-activated protein kinase in metabolic control and insulin signaling.
  JOURNAL   Circ Res 100:328-41 (2007)
REFERENCE   PMID:23899560
  AUTHORS   Richter EA, Hargreaves M
  TITLE     Exercise, GLUT4, and skeletal muscle glucose uptake.
  JOURNAL   Physiol Rev 93:993-1017 (2013)
REFERENCE   PMID:16054041
  AUTHORS   Kahn BB, Alquier T, Carling D, Hardie DG
  TITLE     AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.
  JOURNAL   Cell Metab 1:15-25 (2005)
REFERENCE   PMID:23565491
  AUTHORS   Minokoshi Y, Toda C, Okamoto S
  TITLE     Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle.
  JOURNAL   Indian J Endocrinol Metab 16:S562-8 (2012)
REFERENCE   PMID:16723978
  AUTHORS   Guggino WB, Stanton BA
  TITLE     New insights into cystic fibrosis: molecular switches that regulate CFTR.
  JOURNAL   Nat Rev Mol Cell Biol 7:426-36 (2006)
REFERENCE   PMID:16479585
  AUTHORS   Cheng A, Saltiel AR
  TITLE     More TORC for the gluconeogenic engine.
  JOURNAL   Bioessays 28:231-4 (2006)
REFERENCE   PMID:19197243
  AUTHORS   Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, Jaattela M
  TITLE     TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.
  JOURNAL   EMBO J 28:677-85 (2009)
REFERENCE   PMID:19724019
  AUTHORS   Morris DL, Rui L
  TITLE     Recent advances in understanding leptin signaling and leptin resistance.
  JOURNAL   Am J Physiol Endocrinol Metab 297:E1247-59 (2009)
REFERENCE   PMID:18725075
  AUTHORS   Minokoshi Y, Shiuchi T, Lee S, Suzuki A, Okamoto S
  TITLE     Role of hypothalamic AMP-kinase in food intake regulation.
  JOURNAL   Nutrition 24:786-90 (2008)
REFERENCE   PMID:23024365
  AUTHORS   Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T, Aizawa-Abe M, Yamamoto Y, Fujikura J, Hayashi T, Hosoda K, Nakao K
  TITLE     Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and alpha1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin.
  JOURNAL   J Biol Chem 287:40441-7 (2012)
KO_PATHWAY  ko04152
///
ENTRY       hsa04060                    Pathway
NAME        Cytokine-cytokine receptor interaction - Homo sapiens (human)
DESCRIPTION Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. Cytokines are released by various cells in the body, usually in response to an activating stimulus, and they induce responses through binding to specific receptors on the cell surface of target cells. Cytokines can be grouped by structure into different families and their receptors can likewise be grouped.
CLASS       Environmental Information Processing; Signaling molecules and interaction
PATHWAY_MAP hsa04060  Cytokine-cytokine receptor interaction
DISEASE     H00097  Chemokine receptor defect
            H00227  Congenital amegakaryocytic thrombocytopenia (CAMT)
            H00286  Crohn's disease
            H00344  Leprosy
            H00408  Type I diabetes mellitus
            H00609  46,XY disorders of sex development (Other)
            H00632  Heterotaxy
            H00651  Ectodermal dysplasia
            H00800  Loeys-Dietz syndrome (LDS)
            H00801  Familial thoracic aortic aneurysm and dissection (TAAD)
            H00821  Macular degeneration
            H00912  Tumor necrosis factor receptor-associated periodic syndrome (TRAPS)
            H00935  Cold-induced sweating syndrome (CISS) and Crisponi syndrome (CRISPS)
            H01023  Juvenile polyposis syndrome
            H01024  Hereditary mixed polyposis syndrome
            H01109  Chronic mucocutaneous candidiasis (CMC)
            H01122  Pulmonary alveolar proteinosis (PAP)
            H01217  Primary localized cutaneous amyloidosis (PLCA)
            H01227  Inflammatory bowel disease (IBD)
            H01466  Ulcerative colitis (UC)
            H01479  Castleman disease
DRUG        D00742  Etanercept (genetical recombination) (JAN)
            D00745  Interferon alfa-2a (genetical recombination) (JAN)
            D00746  Interferon beta-1b (genetical recombination) (JAN)
            D00747  Interferon gamma-1b (USAN/INN)
            D00748  Aldesleukin (USAN/INN)
            D01441  Imatinib mesilate (JAN)
            D01977  Gefitinib (JAN/USAN/INN)
            D02596  Tocilizumab (genetical recombination) (JAN)
            D02597  Adalimumab (genetical recombination) (JAN)
            D02598  Infliximab (genetical recombination) (JAN)
            D02691  Somatropin (genetical recombination) (JAN)
            D02743  Celmoleukin (genetical recombination) (JP17)
            D02744  Interferon alfacon-1 (genetical recombination) (JAN)
            D02745  Interferon alfa-2b (genetical recombination) (JAN)
            D02747  Peginterferon alfa-2a (genetical recombination) (JAN)
            D02748  Peginterferon alfa-2b (generical recombination) (JAN)
            D02749  Teceleukin (genetical recombination) (JP17)
            D02934  Anakinra (USAN/INN)
            D03058  Basiliximab (genetical recombination) (JAN)
            D03065  Becaplermin (USAN/INN)
            D03068  Belimumab (genetical recombination) (JAN)
            D03210  Ancriviroc (USAN/INN)
            D03218  Axitinib (JAN/USAN)
            D03231  Epoetin alfa (genetical recombination) (JP17)
            D03232  Epoetin beta (genetical recombination) (JP17)
            D03235  Filgrastim (genetical recombination) (JP17)
            D03245  Nartograstim (genetical recombination) (JP17)
            D03247  Lenograstim (genetical recombination) (JP17)
            D03304  Interferon beta (JAN)
            D03305  Interferon alfa (NAMALWA) (JP17)
            D03350  Canertinib dihydrochloride (USAN)
            D03357  Interferon gamma-1a (genetical recombination) (JAN)
            D03441  Certolizumab pegol (genetical recombination) (JAN)
            D03455  Cetuximab (genetical recombination) (JAN)
            D03639  Daclizumab (USAN/INN)
            D03645  Daniplestim (USAN/INN)
            D03651  Darbepoetin alfa (genetical recombination) (JAN)
            D03658  Dasatinib (INN)
            D03682  Denileukin diftitox (USAN/INN)
            D03684  Denosumab (genetical recombination) (JAN)
            D03978  Eltrombopag olamine (JAN/USAN)
            D04023  Erlotinib hydrochloride (JAN/USAN)
            D04024  Lapatinib tosilate hydrate (JAN)
            D04032  Epoetin delta (USAN)
            D04045  Erlizumab (USAN/INN)
            D04242  Fontolizumab (USAN/INN)
            D04358  Golimumab (genetical recombination) (JAN)
            D04552  Interferon alfa-n1 (USAN)
            D04554  Interferon beta-1a (genetical recombination) (JAN)
            D04612  Iratumumab (USAN)
            D04690  Lenercept (USAN/INN)
            D04695  Leridistim (USAN/INN)
            D04696  Lestaurtinib (USAN/INN)
            D04858  Mapatumumab (USAN/INN)
            D04923  Mepolizumab (genetical recombination) (JAN)
            D05014  Mettreleptin (genetical recombination) (JAN)
            D05029  Midostaurin (USAN/INN)
            D05036  Milodistim (USAN/INN)
            D05066  Molgramostim (USAN/INN)
            D05090  Muplestim (genetical recombination) (JAN)
            D05146  Nerelimomab (USAN/INN)
            D05263  Onercept (USAN/INN)
            D05350  Panitumumab (genetical recombination) (JAN)
            D05380  Pazopanib hydrochloride (JAN/USAN)
            D05386  Pegaptanib sodium (JAN/USAN)
            D05389  Pegnartograstim (USAN/INN)
            D05393  Pegsunercept (USAN)
            D05394  Pegvisomant (genetical recombination) (JAN)
            D05399  Pelitinib (USAN/INN)
            D05697  Ranibizumab (genetical recombination) (JAN)
            D05712  Regramostim (USAN/INN)
            D05777  Ruplizumab (USAN/INN)
            D05803  Sargramostim (USAN/INN)
            D05819  Semaxanib (USAN/INN)
            D05884  Somatrem (genetical recombination) (JAN)
            D06005  Tandutinib (USAN/INN)
            D06071  Teneliximab (USAN/INN)
            D06193  Toralizumab (USAN/INN)
            D06272  Sorafenib tosilate (JAN)
            D06285  Vatalanib (USAN/INN)
            D06297  Vicriviroc maleate (USAN)
            D06402  Sunitinib malate (JAN/USAN)
            D06407  Vandetanib (JAN/USAN/INN)
            D06409  Bevacizumab (genetical recombination) (JAN)
            D06413  Nilotinib hydrochloride hydrate (JAN)
            D06414  Dasatinib hydrate (JAN)
            D06556  Apilimod mesylate (USAN)
            D06557  Aplaviroc hydrochloride (USAN)
            D06611  Lexatumumab (USAN/INN)
            D06635  Rilonacept (USAN/INN)
            D06670  Maraviroc (JAN/INN)
            D06678  Motesanib
            D06889  Pegfilgrastim (genetical recombination) (JAN)
            D07436  Afelimomab (INN)
            D07907  Erlotinib (INN)
            D08066  Imatinib (INN)
            D08108  Lapatinib (INN)
            D08503  Toceranib (USAN)
            D08524  Sorafenib (USAN/INN)
            D08544  Toceranib phosphate (USAN)
            D08552  Sunitinib (INN)
            D08805  Interferon gamma-n1 (JAN)
            D08844  Albinterferon alfa-2b (USAN)
            D08857  Anrukinzumab (USAN)
            D08866  Baminercept (USAN/INN)
            D08874  Bevasiranib sodium (USAN)
            D08877  Briobacept (USAN)
            D08878  Brivanib alaninate (JAN/USAN/INN)
            D08881  Cediranib (USAN/INN)
            D08883  Cediranib maleate (JAN/USAN)
            D08896  Dacetuzumab (USAN)
            D08907  Dovitinib lactate hydrate (JAN)
            D08942  Lucatumumab (USAN)
            D08947  Motesanib phosphate (JAN)
            D08950  Neratinib (INN/USAN)
            D08953  Nilotinib (USAN/INN)
            D08971  Plerixafor (JAN/USAN/INN)
            D08984  Reparixin (USAN/INN)
            D08985  Reslizumab (USAN)
            D08990  Romiplostim (genetical recombination) (JAN)
            D09024  Totrombopag choline (USAN)
            D09214  Ustekinumab (genetical recombination) (JAN)
            D09315  Canakinumab (genetical recombination) (JAN)
            D09329  Conatumumab (USAN/INN)
            D09332  Denenicokin (USAN/INN)
            D09371  Ramucirumab (genetical recombination) (JAN)
            D09574  Aflibercept (genetical recombination) (JAN)
            D09587  Brentuximab vedotin (genetical recombination) (JAN)
            D09588  Briakinumab (USAN/INN)
            D09589  Brivanib (USAN)
            D09615  Fezakinumab (USAN/INN)
            D09618  Foretinib (USAN/INN)
            D09620  Fresolimumab (USAN/INN)
            D09633  Lebrikizumab (genetical recombination) (JAN)
            D09635  Linifanib (USAN/INN)
            D09659  Rilotumumab (USAN/INN)
            D09662  Rontalizumab (USAN/INN)
            D09668  Sifalimumab (USAN/INN)
            D09669  Siltuximab (USAN/INN)
            D09670  Sotatercept (USAN/INN)
            D09683  Tivozanib (USAN/INN)
            D09704  Atacicept (USAN/INN)
            D09724  Afatinib (USAN/INN)
            D09733  Afatinib maleate (JAN)
            D09737  Epoetin kappa (genetical recombination) (Epoetin alfa biosimilar 1) (JAN)
            D09761  Mogamulizumab (genetical recombination) (JAN)
            D09864  Amuvatinib (USAN/INN)
            D09865  Amuvatinib hydrochloride (USAN)
            D09874  Benralizumab (USAN/INN)
            D09877  Carlumab (USAN)
            D09888  Drozitumab (USAN/INN)
            D09896  Enavatuzumab (USAN/INN)
            D09897  Enokizumab (USAN/INN)
            D09911  Gevokizumab (USAN/INN)
            D09919  Lenvatinib (USAN/INN)
            D09920  Lenvatinib mesilate (JAN)
            D09926  Icrucumab (USAN/INN)
            D09930  Mavrilimumab (USAN/INN)
            D09939  Olaratumab (USAN/INN)
            D09941  Onartuzumab (genetical recombination) (JAN)
            D09944  Ozoralizumab (USAN)
            D09945  Pegdinetanib (USAN/INN)
            D09946  Peginesatide (USAN/INN)
            D09947  Peginesatide acetate (JAN/USAN)
            D09955  Quizartinib (USAN/INN)
            D09956  Quizartinib dihydrochloride (USAN)
            D09967  Secukinumab (genetical recombination) (JAN)
            D09979  Tralokinumab (USAN/INN)
            D09984  Urelumab (USAN/INN)
            D09998  Epoetin beta pegol (genetical recombination) (JAN)
            D10000  Epoetin epsilon (genetical recombination) (JAN)
            D10018  Necitumumab (USAN/INN)
            D10031  Zalutumumab (USAN/INN)
            D10061  Brodalumab (genetical recombination) (JAN)
            D10062  Cabozantinib (USAN)
            D10071  Ixekizumab (genetical recombination) (JAN)
            D10075  Navarixin (USAN)
            D10078  Peginterferon lambda-1a (USAN)
            D10080  Sirukumab (genetical recombination) (JAN)
            D10083  Tabalumab (genetical recombination) (JAN)
            D10102  Crenolanib (USAN)
            D10103  Crenolanib besylate (USAN)
            D10123  Ficlatuzumab (USAN)
            D10137  Regorafenib hydrate (JAN)
            D10138  Regorafenib (USAN/INN)
            D10161  Sarilumab (USAN)
            D10173  Tivantinib (JAN/USAN/INN)
            D10187  Pateclizumab (USAN)
            D10190  Tivozanib hydrochloride (USAN)
            D10224  Golvatinib (USAN)
            D10229  Masitinib (INN)
            D10242  Lipegfilgrastim (USAN)
            D10332  Elubrixin (USAN)
            D10341  Vorsetuzumab mafodotin (USAN/INN)
            D10342  Vorsetuzumab (USAN/INN)
            D10354  Dupilumab (USAN)
            D10378  Vercirnon (USAN/INN)
            D10379  Vercirnon sodium (USAN)
            D10387  Danirixin (USAN/INN)
            D10420  Elubrixin tosylate (USAN)
            D10465  Golvatinib tartrate (USAN)
            D10476  Lusutrombopag (JAN/USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]
            2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]
            2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]
            6374  CXCL5; C-X-C motif chemokine ligand 5 [KO:K05506]
            6372  CXCL6; C-X-C motif chemokine ligand 6 [KO:K05506]
            5473  PPBP; pro-platelet basic protein [KO:K10029]
            3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]
            4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]
            3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]
            6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]
            6387  CXCL12; C-X-C motif chemokine ligand 12 [KO:K10031]
            10563  CXCL13; C-X-C motif chemokine ligand 13 [KO:K10032]
            58191  CXCL16; C-X-C motif chemokine ligand 16 [KO:K10035]
            5196  PF4; platelet factor 4 [KO:K05407]
            5197  PF4V1; platelet factor 4 variant 1 [KO:K05407]
            9547  CXCL14; C-X-C motif chemokine ligand 14 [KO:K10033]
            6375  XCL1; X-C motif chemokine ligand 1 [KO:K05507]
            6846  XCL2; X-C motif chemokine ligand 2 [KO:K05507]
            6376  CX3CL1; C-X3-C motif chemokine ligand 1 [KO:K05508]
            6346  CCL1; C-C motif chemokine ligand 1 [KO:K05514]
            6358  CCL14; C-C motif chemokine ligand 14 [KO:K05514]
            6360  CCL16; C-C motif chemokine ligand 16 [KO:K05514]
            6361  CCL17; C-C motif chemokine ligand 17 [KO:K05514]
            6362  CCL18; C-C motif chemokine ligand 18 [KO:K05514]
            6367  CCL22; C-C motif chemokine ligand 22 [KO:K05514]
            6369  CCL24; C-C motif chemokine ligand 24 [KO:K05514]
            10344  CCL26; C-C motif chemokine ligand 26 [KO:K05514]
            6364  CCL20; C-C motif chemokine ligand 20 [KO:K14625]
            6370  CCL25; C-C motif chemokine ligand 25 [KO:K13072]
            6363  CCL19; C-C motif chemokine ligand 19 [KO:K05512]
            6366  CCL21; C-C motif chemokine ligand 21 [KO:K16062]
            6347  CCL2; C-C motif chemokine ligand 2 [KO:K14624]
            6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]
            9560  CCL4L2; chemokine (C-C motif) ligand 4-like 2 [KO:K12964]
            388372  CCL4L1; chemokine (C-C motif) ligand 4-like 1 [KO:K12964]
            6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]
            6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]
            414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]
            6357  CCL13; C-C motif chemokine ligand 13 [KO:K16595]
            6354  CCL7; C-C motif chemokine ligand 7 [KO:K05509]
            6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]
            6359  CCL15; C-C motif chemokine ligand 15 [KO:K05511]
            6368  CCL23; C-C motif chemokine ligand 23 [KO:K05511]
            6355  CCL8; C-C motif chemokine ligand 8 [KO:K16596]
            6356  CCL11; C-C motif chemokine ligand 11 [KO:K16597]
            56477  CCL28; C-C motif chemokine ligand 28 [KO:K05513]
            10850  CCL27; C-C motif chemokine ligand 27 [KO:K16598]
            3569  IL6; interleukin 6 [KO:K05405]
            3589  IL11; interleukin 11 [KO:K05417]
            5008  OSM; oncostatin M [KO:K05418]
            3976  LIF; leukemia inhibitory factor [KO:K05419]
            1270  CNTF; ciliary neurotrophic factor [KO:K05420]
            23529  CLCF1; cardiotrophin-like cytokine factor 1 [KO:K05421]
            1489  CTF1; cardiotrophin 1 [KO:K05422]
            1440  CSF3; colony stimulating factor 3 [KO:K05423]
            3952  LEP; leptin [KO:K05424]
            3565  IL4; interleukin 4 [KO:K05430]
            3596  IL13; interleukin 13 [KO:K05435]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            51561  IL23A; interleukin 23 subunit alpha [KO:K05426]
            1437  CSF2; colony stimulating factor 2 [KO:K05427]
            3562  IL3; interleukin 3 [KO:K04736]
            3567  IL5; interleukin 5 [KO:K05428]
            3558  IL2; interleukin 2 [KO:K05429]
            3574  IL7; interleukin 7 [KO:K05431]
            3578  IL9; interleukin 9 [KO:K05432]
            3600  IL15; interleukin 15 [KO:K05433]
            59067  IL21; interleukin 21 [KO:K05434]
            85480  TSLP; thymic stromal lymphopoietin [KO:K05436]
            2056  EPO; erythropoietin [KO:K05437]
            2688  GH1; growth hormone 1 [KO:K05438]
            2689  GH2; growth hormone 2 [KO:K05438]
            5617  PRL; prolactin [KO:K05439]
            7066  THPO; thrombopoietin [KO:K06854]
            56034  PDGFC; platelet derived growth factor C [KO:K05450]
            5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]
            5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            7423  VEGFB; vascular endothelial growth factor B [KO:K16858]
            7424  VEGFC; vascular endothelial growth factor C [KO:K05449]
            2277  FIGF; c-fos induced growth factor (vascular endothelial growth factor D) [KO:K05449]
            3082  HGF; hepatocyte growth factor [KO:K05460]
            1950  EGF; epidermal growth factor [KO:K04357]
            1435  CSF1; colony stimulating factor 1 [KO:K05453]
            4254  KITLG; KIT ligand [KO:K05461]
            2323  FLT3LG; fms related tyrosine kinase 3 ligand [KO:K05454]
            3439  IFNA1; interferon, alpha 1 [KO:K05414]
            3440  IFNA2; interferon, alpha 2 [KO:K05414]
            3441  IFNA4; interferon, alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon, alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon, alpha 10 [KO:K05414]
            3447  IFNA13; interferon, alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon, alpha 16 [KO:K05414]
            3451  IFNA17; interferon, alpha 17 [KO:K05414]
            3452  IFNA21; interferon, alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3467  IFNW1; interferon, omega 1 [KO:K05440]
            56832  IFNK; interferon kappa [KO:K05441]
            338376  IFNE; interferon, epsilon [KO:K05442]
            3458  IFNG; interferon, gamma [KO:K04687]
            3586  IL10; interleukin 10 [KO:K05443]
            29949  IL19; interleukin 19 [KO:K05444]
            50604  IL20; interleukin 20 [KO:K05444]
            11009  IL24; interleukin 24 [KO:K05444]
            50616  IL22; interleukin 22 [KO:K05445]
            282616  IFNL2; interferon, lambda 2 [KO:K05447]
            282617  IFNL3; interferon, lambda 3 [KO:K05447]
            282618  IFNL1; interferon, lambda 1 [KO:K05447]
            55801  IL26; interleukin 26 [KO:K05446]
            9966  TNFSF15; tumor necrosis factor superfamily member 15 [KO:K05478]
            8743  TNFSF10; tumor necrosis factor superfamily member 10 [KO:K04721]
            8600  TNFSF11; tumor necrosis factor superfamily member 11 [KO:K05473]
            8742  TNFSF12; tumor necrosis factor superfamily member 12 [KO:K05474]
            7124  TNF; tumor necrosis factor [KO:K03156]
            4049  LTA; lymphotoxin alpha [KO:K05468]
            4050  LTB; lymphotoxin beta [KO:K03157]
            8740  TNFSF14; tumor necrosis factor superfamily member 14 [KO:K05477]
            356  FASLG; Fas ligand [KO:K04389]
            959  CD40LG; CD40 ligand [KO:K03161]
            970  CD70; CD70 molecule [KO:K05470]
            944  TNFSF8; tumor necrosis factor superfamily member 8 [KO:K05471]
            8744  TNFSF9; tumor necrosis factor superfamily member 9 [KO:K05472]
            7292  TNFSF4; tumor necrosis factor superfamily member 4 [KO:K05469]
            8995  TNFSF18; tumor necrosis factor superfamily member 18 [KO:K05479]
            8741  TNFSF13; tumor necrosis factor superfamily member 13 [KO:K05475]
            10673  TNFSF13B; tumor necrosis factor superfamily member 13b [KO:K05476]
            1896  EDA; ectodysplasin A [KO:K05480]
            7040  TGFB1; transforming growth factor beta 1 [KO:K13375]
            7042  TGFB2; transforming growth factor beta 2 [KO:K13376]
            7043  TGFB3; transforming growth factor beta 3 [KO:K13377]
            3624  INHBA; inhibin beta A [KO:K04667]
            3625  INHBB; inhibin beta B [KO:K04667]
            3626  INHBC; inhibin beta C [KO:K04667]
            83729  INHBE; inhibin beta E [KO:K04667]
            268  AMH; anti-Mullerian hormone [KO:K04665]
            650  BMP2; bone morphogenetic protein 2 [KO:K04662]
            655  BMP7; bone morphogenetic protein 7 [KO:K16621]
            8200  GDF5; growth differentiation factor 5 [KO:K04664]
            3605  IL17A; interleukin 17A [KO:K05489]
            27190  IL17B; interleukin 17B [KO:K05490]
            64806  IL25; interleukin 25 [KO:K05493]
            3552  IL1A; interleukin 1 alpha [KO:K04383]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            3606  IL18; interleukin 18 [KO:K05482]
            3579  CXCR2; C-X-C motif chemokine receptor 2 [KO:K05050]
            3577  CXCR1; C-X-C motif chemokine receptor 1 [KO:K04175]
            2833  CXCR3; C-X-C motif chemokine receptor 3 [KO:K04188]
            7852  CXCR4; C-X-C motif chemokine receptor 4 [KO:K04189]
            643  CXCR5; C-X-C motif chemokine receptor 5 [KO:K04190]
            10663  CXCR6; C-X-C motif chemokine receptor 6 [KO:K04191]
            57007  ACKR3; atypical chemokine receptor 3 [KO:K04304]
            2829  XCR1; X-C motif chemokine receptor 1 [KO:K04193]
            1524  CX3CR1; C-X3-C motif chemokine receptor 1 [KO:K04192]
            1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]
            1235  CCR6; C-C motif chemokine receptor 6 [KO:K04181]
            10803  CCR9; C-C motif chemokine receptor 9 [KO:K04184]
            1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]
            1236  CCR7; C-C motif chemokine receptor 7 [KO:K04182]
            729230  CCR2; C-C motif chemokine receptor 2 [KO:K04177]
            1234  CCR5; C-C motif chemokine receptor 5 (gene/pseudogene) [KO:K04180]
            1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]
            1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]
            2826  CCR10; C-C motif chemokine receptor 10 [KO:K04185]
            3570  IL6R; interleukin 6 receptor [KO:K05055]
            3572  IL6ST; interleukin 6 signal transducer [KO:K05060]
            3590  IL11RA; interleukin 11 receptor subunit alpha [KO:K05056]
            3977  LIFR; leukemia inhibitory factor receptor alpha [KO:K05058]
            9180  OSMR; oncostatin M receptor [KO:K05057]
            1271  CNTFR; ciliary neurotrophic factor receptor [KO:K05059]
            1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]
            3953  LEPR; leptin receptor [KO:K05062]
            3566  IL4R; interleukin 4 receptor [KO:K05071]
            3597  IL13RA1; interleukin 13 receptor subunit alpha 1 [KO:K05076]
            3594  IL12RB1; interleukin 12 receptor subunit beta 1 [KO:K05063]
            3595  IL12RB2; interleukin 12 receptor subunit beta 2 [KO:K05064]
            149233  IL23R; interleukin 23 receptor [KO:K05065]
            1438  CSF2RA; colony stimulating factor 2 receptor alpha subunit [KO:K05066]
            1439  CSF2RB; colony stimulating factor 2 receptor beta common subunit [KO:K04738]
            3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]
            3568  IL5RA; interleukin 5 receptor subunit alpha [KO:K05067]
            3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]
            3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]
            3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
            3575  IL7R; interleukin 7 receptor [KO:K05072]
            3581  IL9R; interleukin 9 receptor [KO:K05073]
            3601  IL15RA; interleukin 15 receptor subunit alpha [KO:K05074]
            50615  IL21R; interleukin 21 receptor [KO:K05075]
            64109  CRLF2; cytokine receptor-like factor 2 [KO:K05078]
            2057  EPOR; erythropoietin receptor [KO:K05079]
            2690  GHR; growth hormone receptor [KO:K05080]
            5618  PRLR; prolactin receptor [KO:K05081]
            4352  MPL; MPL proto-oncogene, thrombopoietin receptor [KO:K05082]
            5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
            5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
            2321  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
            3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
            2324  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
            4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
            3815  KIT; KIT proto-oncogene receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]
            2322  FLT3; fms related tyrosine kinase 3 [KO:K05092] [EC:2.7.10.1]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) [KO:K05133]
            3587  IL10RA; interleukin 10 receptor subunit alpha [KO:K05134]
            3588  IL10RB; interleukin 10 receptor subunit beta [KO:K05135]
            53832  IL20RA; interleukin 20 receptor subunit alpha [KO:K05136]
            53833  IL20RB; interleukin 20 receptor subunit beta [KO:K05137]
            58985  IL22RA1; interleukin 22 receptor subunit alpha 1 [KO:K05138]
            116379  IL22RA2; interleukin 22 receptor subunit alpha 2 [KO:K05139]
            163702  IFNLR1; interferon lambda receptor 1 [KO:K05140]
            8797  TNFRSF10A; tumor necrosis factor receptor superfamily member 10a [KO:K04722]
            8795  TNFRSF10B; tumor necrosis factor receptor superfamily member 10b [KO:K04722]
            8794  TNFRSF10C; tumor necrosis factor receptor superfamily member 10c [KO:K04722]
            8793  TNFRSF10D; tumor necrosis factor receptor superfamily member 10d [KO:K04722]
            4982  TNFRSF11B; tumor necrosis factor receptor superfamily member 11b [KO:K05148]
            8792  TNFRSF11A; tumor necrosis factor receptor superfamily member 11a [KO:K05147]
            8718  TNFRSF25; tumor necrosis factor receptor superfamily member 25 [KO:K05160]
            51330  TNFRSF12A; tumor necrosis factor receptor superfamily member 12A [KO:K05149]
            27242  TNFRSF21; tumor necrosis factor receptor superfamily member 21 [KO:K05157]
            4804  NGFR; nerve growth factor receptor [KO:K02583]
            7133  TNFRSF1B; tumor necrosis factor receptor superfamily member 1B [KO:K05141]
            7132  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
            4055  LTBR; lymphotoxin beta receptor [KO:K03159]
            8764  TNFRSF14; tumor necrosis factor receptor superfamily member 14 [KO:K05152]
            8771  TNFRSF6B; tumor necrosis factor receptor superfamily member 6b [KO:K05143]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            958  CD40; CD40 molecule [KO:K03160]
            939  CD27; CD27 molecule [KO:K05144]
            943  TNFRSF8; tumor necrosis factor receptor superfamily member 8 [KO:K05145]
            3604  TNFRSF9; tumor necrosis factor receptor superfamily member 9 [KO:K05146]
            7293  TNFRSF4; tumor necrosis factor receptor superfamily member 4 [KO:K05142]
            8784  TNFRSF18; tumor necrosis factor receptor superfamily member 18 [KO:K05154]
            608  TNFRSF17; tumor necrosis factor receptor superfamily member 17 [KO:K05153]
            23495  TNFRSF13B; tumor necrosis factor receptor superfamily member 13B [KO:K05150]
            115650  TNFRSF13C; tumor necrosis factor receptor superfamily member 13C [KO:K05151]
            10913  EDAR; ectodysplasin A receptor [KO:K05162]
            60401  EDA2R; ectodysplasin A2 receptor [KO:K05163]
            55504  TNFRSF19; tumor necrosis factor receptor superfamily member 19 [KO:K05155]
            84957  RELT; RELT tumor necrosis factor receptor [KO:K05156]
            7048  TGFBR2; transforming growth factor beta receptor II [KO:K04388] [EC:2.7.11.30]
            7046  TGFBR1; transforming growth factor beta receptor I [KO:K04674] [EC:2.7.11.30]
            92  ACVR2A; activin A receptor type 2A [KO:K04670] [EC:2.7.11.30]
            93  ACVR2B; activin A receptor type 2B [KO:K13596] [EC:2.7.11.30]
            90  ACVR1; activin A receptor type 1 [KO:K04675] [EC:2.7.11.30]
            91  ACVR1B; activin A receptor type 1B [KO:K13567] [EC:2.7.11.30]
            269  AMHR2; anti-Mullerian hormone receptor type II [KO:K04672] [EC:2.7.11.30]
            659  BMPR2; bone morphogenetic protein receptor type II [KO:K04671] [EC:2.7.11.30]
            657  BMPR1A; bone morphogenetic protein receptor type 1A [KO:K04673] [EC:2.7.11.30]
            658  BMPR1B; bone morphogenetic protein receptor type 1B [KO:K13578] [EC:2.7.11.30]
            23765  IL17RA; interleukin 17 receptor A [KO:K05164]
            55540  IL17RB; interleukin 17 receptor B [KO:K05165]
            3554  IL1R1; interleukin 1 receptor type 1 [KO:K04386]
            3556  IL1RAP; interleukin 1 receptor accessory protein [KO:K04723]
            7850  IL1R2; interleukin 1 receptor type 2 [KO:K04387]
            8809  IL18R1; interleukin 18 receptor 1 [KO:K05173]
            8807  IL18RAP; interleukin 18 receptor accessory protein [KO:K05174]
            80301  PLEKHO2; pleckstrin homology domain containing O2
REFERENCE   
  AUTHORS   Oppenheim JJ, Feldman M (ed).
  TITLE     Cytokine Reference
  JOURNAL   Academic Press (2001)
REFERENCE   
  AUTHORS   Thomson AW, Lotze MT (ed).
  TITLE     The Cytokine Handbook (Fourth edition)
  JOURNAL   Academic Press (2003)
REFERENCE   PMID:10714678
  AUTHORS   Zlotnik A, Yoshie O.
  TITLE     Chemokines: a new classification system and their role in immunity.
  JOURNAL   Immunity 12:121-7 (2000)
REFERENCE   PMID:12072446
  AUTHORS   Ozaki K, Leonard WJ.
  TITLE     Cytokine and cytokine receptor pleiotropy and redundancy.
  JOURNAL   J Biol Chem 277:29355-8 (2002)
REFERENCE   PMID:12039028
  AUTHORS   Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW.
  TITLE     Signaling through the JAK/STAT pathway, recent advances and future challenges.
  JOURNAL   Gene 285:1-24 (2002)
REFERENCE   PMID:12651221
  AUTHORS   Li X, Eriksson U.
  TITLE     Novel PDGF family members: PDGF-C and PDGF-D.
  JOURNAL   Cytokine Growth Factor Rev 14:91-8 (2003)
REFERENCE   PMID:11312110
  AUTHORS   Li X, Eriksson U.
  TITLE     Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D.
  JOURNAL   Int J Biochem Cell Biol 33:421-6 (2001)
REFERENCE   PMID:11166270
  AUTHORS   Zachary I, Gliki G.
  TITLE     Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.
  JOURNAL   Cardiovasc Res 49:568-81 (2001)
REFERENCE   PMID:11071910
  AUTHORS   Dey A, She H, Kim L, Boruch A, Guris DL, Carlberg K, Sebti SM, Woodley DT, Imamoto A, Li W.
  TITLE     Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression.
  JOURNAL   Mol Biol Cell 11:3835-48 (2000)
REFERENCE   PMID:15032600
  AUTHORS   Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB.
  TITLE     Interleukin-10 and related cytokines and receptors.
  JOURNAL   Annu Rev Immunol 22:929-79 (2004)
REFERENCE   PMID:11796220
  AUTHORS   Bodmer JL, Schneider P, Tschopp J.
  TITLE     The molecular architecture of the TNF superfamily.
  JOURNAL   Trends Biochem Sci 27:19-26 (2002)
REFERENCE   PMID:9395284
  AUTHORS   Derynck R, Feng XH.
  TITLE     TGF-beta receptor signaling.
  JOURNAL   Biochim Biophys Acta 1333:F105-50 (1997)
REFERENCE   PMID:7791754
  AUTHORS   Liu F, Ventura F, Doody J, Massague J.
  TITLE     Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs.
  JOURNAL   Mol Cell Biol 15:3479-86 (1995)
REFERENCE   PMID:9759503
  AUTHORS   Massague J.
  TITLE     TGF-beta signal transduction.
  JOURNAL   Annu Rev Biochem 67:753-91 (1998)
REFERENCE   PMID:11252892
  AUTHORS   Massague J.
  TITLE     How cells read TGF-beta signals.
  JOURNAL   Nat Rev Mol Cell Biol 1:169-78 (2000)
REFERENCE   PMID:12651226
  AUTHORS   Moseley TA, Haudenschild DR, Rose L, Reddi AH.
  TITLE     Interleukin-17 family and IL-17 receptors.
  JOURNAL   Cytokine Growth Factor Rev 14:155-74 (2003)
REFERENCE   PMID:12421671
  AUTHORS   Martin MU, Wesche H.
  TITLE     Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.
  JOURNAL   Biochim Biophys Acta 1592:265-80 (2002)
REFERENCE   PMID:9862719
  AUTHORS   Lang D, Knop J, Wesche H, Raffetseder U, Kurrle R, Boraschi D, Martin MU.
  TITLE     The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness.
  JOURNAL   J Immunol 161:6871-7 (1998)
KO_PATHWAY  ko04060
///
ENTRY       hsa04611                    Pathway
NAME        Platelet activation - Homo sapiens (human)
DESCRIPTION Platelets play a key and beneficial role for primary hemostasis on the disruption of the integrity of vessel wall. Platelet adhesion and activation at sites of vascular wall injury is initiated by adhesion to adhesive macromolecules, such as collagen and von Willebrand factor (vWF), or by soluble platelet agonists, such as ADP, thrombin, and thromboxane A2. Different receptors are stimulated by various agonists, almost converging in increasing intracellular Ca2+ concentration that stimulate platelet shape change and granule secretion and ultimately induce the "inside-out" signaling process leading to activation of the ligand-binding function of integrin alpha IIb beta 3. Binding of alpha IIb beta 3 to its ligands, mainly fibrinogen, mediates platelet adhesion and aggregation and triggers "outside-in" signaling, resulting in platelet spreading, additional granule secretion, stabilization of platelet adhesion and aggregation, and clot retraction.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04611  Platelet activation
DBLINKS     BSID: 952858
            GO: 0030168
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        6915  TBXA2R; thromboxane A2 receptor [KO:K04264]
            2149  F2R; coagulation factor II thrombin receptor [KO:K03914]
            9002  F2RL3; F2R like thrombin/trypsin receptor 3 [KO:K04236]
            10672  GNA13; G protein subunit alpha 13 [KO:K04639]
            9138  ARHGEF1; Rho guanine nucleotide exchange factor 1 [KO:K12330]
            23365  ARHGEF12; Rho guanine nucleotide exchange factor 12 [KO:K07532]
            387  RHOA; ras homolog family member A [KO:K04513]
            6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]
            9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
            5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
            5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
            5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
            4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]
            103910  MYL12B; myosin light chain 12B [KO:K12757]
            10627  MYL12A; myosin light chain 12A [KO:K12757]
            5023  P2RX1; purinergic receptor P2X 1 [KO:K05215]
            84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            6786  STIM1; stromal interaction molecule 1 [KO:K16059]
            4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]
            85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
            91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
            340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]
            5028  P2RY1; purinergic receptor P2Y1 [KO:K04270]
            2776  GNAQ; G protein subunit alpha q [KO:K04634]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            5590  PRKCZ; protein kinase C zeta [KO:K18952] [EC:2.7.11.13]
            5584  PRKCI; protein kinase C iota [KO:K06069] [EC:2.7.11.13]
            10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]
            10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]
            5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
            5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
            54518  APBB1IP; amyloid beta precursor protein binding family B member 1 interacting protein [KO:K17704]
            7094  TLN1; talin 1 [KO:K06271]
            83660  TLN2; talin 2 [KO:K06271]
            3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            83706  FERMT3; fermitin family member 3 [KO:K17084]
            2243  FGA; fibrinogen alpha chain [KO:K03903]
            2244  FGB; fibrinogen beta chain [KO:K03904]
            2266  FGG; fibrinogen gamma chain [KO:K03905]
            64805  P2RY12; purinergic receptor P2Y12 [KO:K04298]
            2770  GNAI1; G protein subunit alpha i1 [KO:K04630]
            2773  GNAI3; G protein subunit alpha i3 [KO:K04630]
            2771  GNAI2; G protein subunit alpha i2 [KO:K04630]
            107  ADCY1; adenylate cyclase 1 (brain) [KO:K08041] [EC:4.6.1.1]
            108  ADCY2; adenylate cyclase 2 (brain) [KO:K08042] [EC:4.6.1.1]
            109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
            113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            114  ADCY8; adenylate cyclase 8 (brain) [KO:K08048] [EC:4.6.1.1]
            115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            5739  PTGIR; prostaglandin I2 (prostacyclin) receptor (IP) [KO:K04263]
            2778  GNAS; GNAS complex locus [KO:K04632]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            7408  VASP; vasodilator-stimulated phosphoprotein [KO:K06274]
            60  ACTB; actin, beta [KO:K05692]
            71  ACTG1; actin gamma 1 [KO:K05692]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            2909  ARHGAP35; Rho GTPase activating protein 35 [KO:K05732]
            2212  FCGR2A; Fc fragment of IgG receptor IIa [KO:K06472]
            6850  SYK; spleen tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            1277  COL1A1; collagen type I alpha 1 [KO:K06236]
            1278  COL1A2; collagen type I alpha 2 [KO:K06236]
            1281  COL3A1; collagen type III alpha 1 [KO:K19720]
            51206  GP6; glycoprotein VI platelet [KO:K06264]
            2207  FCER1G; Fc fragment of IgE receptor Ig [KO:K07983]
            4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
            2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
            3673  ITGA2; integrin subunit alpha 2 [KO:K06481]
            3688  ITGB1; integrin subunit beta 1 [KO:K05719]
            3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            695  BTK; Bruton tyrosine kinase [KO:K07370] [EC:2.7.10.2]
            7450  VWF; von Willebrand factor [KO:K03900]
            2814  GP5; glycoprotein V platelet [KO:K06260]
            2811  GP1BA; glycoprotein Ib platelet alpha subunit [KO:K06261]
            2812  GP1BB; glycoprotein Ib platelet beta subunit [KO:K06262]
            2815  GP9; glycoprotein IX platelet [KO:K06263]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]
            2977  GUCY1A2; guanylate cyclase 1, soluble, alpha 2 [KO:K12318] [EC:4.6.1.2]
            2982  GUCY1A3; guanylate cyclase 1, soluble, alpha 3 [KO:K12318] [EC:4.6.1.2]
            2983  GUCY1B3; guanylate cyclase 1, soluble, beta 3 [KO:K12319] [EC:4.6.1.2]
            5592  PRKG1; protein kinase, cGMP-dependent, type I [KO:K07376] [EC:2.7.11.12]
            5593  PRKG2; protein kinase, cGMP-dependent, type II [KO:K19477] [EC:2.7.11.12]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]
            5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]
            8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]
            100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]
            8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]
            283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]
            255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]
            5742  PTGS1; prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) [KO:K00509] [EC:1.14.99.1]
            6916  TBXAS1; thromboxane A synthase 1 [KO:K01832] [EC:5.3.99.5]
            8773  SNAP23; synaptosome associated protein 23kDa [KO:K08508]
            8673  VAMP8; vesicle associated membrane protein 8 [KO:K08512]
COMPOUND    C00002  ATP
            C00008  ADP
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00219  Arachidonate
            C00427  Prostaglandin H2
            C00533  Nitric oxide
            C00575  3',5'-Cyclic AMP
            C00752  Thrombin
            C00942  3',5'-Cyclic GMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01312  Prostaglandin I2
            C02198  Thromboxane A2
            C05956  Prostaglandin G2
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:21071698
  AUTHORS   Li Z, Delaney MK, O'Brien KA, Du X
  TITLE     Signaling during platelet adhesion and activation.
  JOURNAL   Arterioscler Thromb Vasc Biol 30:2341-9 (2010)
REFERENCE   PMID:22119499
  AUTHORS   Broos K, De Meyer SF, Feys HB, Vanhoorelbeke K, Deckmyn H
  TITLE     Blood platelet biochemistry.
  JOURNAL   Thromb Res 129:245-9 (2012)
REFERENCE   PMID:16149014
  AUTHORS   Jurk K, Kehrel BE
  TITLE     Platelets: physiology and biochemistry.
  JOURNAL   Semin Thromb Hemost 31:381-92 (2005)
REFERENCE   PMID:17158345
  AUTHORS   Offermanns S
  TITLE     Activation of platelet function through G protein-coupled receptors.
  JOURNAL   Circ Res 99:1293-304 (2006)
REFERENCE   PMID:18174460
  AUTHORS   Varga-Szabo D, Pleines I, Nieswandt B
  TITLE     Cell adhesion mechanisms in platelets.
  JOURNAL   Arterioscler Thromb Vasc Biol 28:403-12 (2008)
REFERENCE   PMID:18550847
  AUTHORS   Yin H, Liu J, Li Z, Berndt MC, Lowell CA, Du X
  TITLE     Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway.
  JOURNAL   Blood 112:1139-46 (2008)
REFERENCE   PMID:19630797
  AUTHORS   Bergmeier W, Stefanini L
  TITLE     Novel molecules in calcium signaling in platelets.
  JOURNAL   J Thromb Haemost 7 Suppl 1:187-90 (2009)
REFERENCE   PMID:18544684
  AUTHORS   Cifuni SM, Wagner DD, Bergmeier W
  TITLE     CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets.
  JOURNAL   Blood 112:1696-703 (2008)
REFERENCE   PMID:23106920
  AUTHORS   Heemskerk JW, Mattheij NJ, Cosemans JM
  TITLE     Platelet-based coagulation: different populations, different functions.
  JOURNAL   J Thromb Haemost 11:2-16 (2013)
REFERENCE   PMID:19286885
  AUTHORS   Rivera J, Lozano ML, Navarro-Nunez L, Vicente V
  TITLE     Platelet receptors and signaling in the dynamics of thrombus formation.
  JOURNAL   Haematologica 94:700-11 (2009)
REFERENCE   PMID:18363565
  AUTHORS   Banno A, Ginsberg MH
  TITLE     Integrin activation.
  JOURNAL   Biochem Soc Trans 36:229-34 (2008)
REFERENCE   PMID:20089227
  AUTHORS   Angiolillo DJ, Ferreiro JL
  TITLE     Platelet adenosine diphosphate P2Y12 receptor antagonism: benefits and limitations of current treatment strategies and future directions.
  JOURNAL   Rev Esp Cardiol 63:60-76 (2010)
REFERENCE   PMID:22701130
  AUTHORS   Joo SJ
  TITLE     Mechanisms of Platelet Activation and Integrin alphaIIbeta3.
  JOURNAL   Korean Circ J 42:295-301 (2012)
REFERENCE   PMID:20002545
  AUTHORS   Harper MT, Poole AW
  TITLE     Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.
  JOURNAL   J Thromb Haemost 8:454-62 (2010)
REFERENCE   PMID:23805129
  AUTHORS   Fitch-Tewfik JL, Flaumenhaft R
  TITLE     Platelet granule exocytosis: a comparison with chromaffin cells.
  JOURNAL   Front Endocrinol (Lausanne) 4:77 (2013)
REFERENCE   PMID:18641368
  AUTHORS   Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ
  TITLE     Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets.
  JOURNAL   Blood 112:2780-6 (2008)
KO_PATHWAY  ko04611
///
ENTRY       hsa04620                    Pathway
NAME        Toll-like receptor signaling pathway - Homo sapiens (human)
DESCRIPTION Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified as homologs of Toll in Drosophila. Mammalian TLRs are expressed on innate immune cells, such as macrophages and dendritic cells, and respond to the membrane components of Gram-positive or Gram-negative bacteria. Pathogen recognition by TLRs provokes rapid activation of innate immunity by inducing production of proinflammatory cytokines and upregulation of costimulatory molecules. TLR signaling pathways are separated into two groups: a MyD88-dependent pathway that leads to the production of proinflammatory cytokines with quick activation of NF-{kappa}B and MAPK, and a MyD88-independent pathway associated with the induction of IFN-beta and IFN-inducible genes, and maturation of dendritic cells with slow activation of NF-{kappa}B and MAPK.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04620  Toll-like receptor signaling pathway
MODULE      hsa_M00686  Toll-like receptor signaling [PATH:hsa04620]
DISEASE     H00096  Defects of toll-like receptor signaling
            H00273  Pycnodysostosis
            H00344  Leprosy
            H00425  Lysosomal cysteine protease deficiencies
            H00721  Pyogenic bacterial infections, recurrent, due to MYD88 deficiency
            H00821  Macular degeneration
            H00882  Cocoon syndrome
            H01109  Chronic mucocutaneous candidiasis (CMC)
            H01502  Sjogren's Syndrome
DRUG        D00745  Interferon alfa-2a (genetical recombination) (JAN)
            D00746  Interferon beta-1b (genetical recombination) (JAN)
            D02500  Imiquimod (JAN/USAN/INN)
            D02744  Interferon alfacon-1 (genetical recombination) (JAN)
            D02745  Interferon alfa-2b (genetical recombination) (JAN)
            D02747  Peginterferon alfa-2a (genetical recombination) (JAN)
            D02748  Peginterferon alfa-2b (generical recombination) (JAN)
            D03203  Abatacept (genetical recombination) (JAN)
            D03304  Interferon beta (JAN)
            D03305  Interferon alfa (NAMALWA) (JP17)
            D03441  Certolizumab pegol (genetical recombination) (JAN)
            D04043  Eritoran tetrasodium (USAN)
            D04295  Galiximab (USAN/INN)
            D04552  Interferon alfa-n1 (USAN)
            D04554  Interferon beta-1a (genetical recombination) (JAN)
            D04619  Isatoribine (USAN)
            D04787  Loxoribine (USAN/INN)
            D06071  Teneliximab (USAN/INN)
            D06634  Relacatib (USAN/INN)
            D06635  Rilonacept (USAN/INN)
            D08841  Agatolimod (USAN)
            D08842  Agatolimod sodium (USAN)
            D08844  Albinterferon alfa-2b (USAN)
            D08955  Odanacatib (JAN/USAN)
            D09573  Eritoran sodium (JAN)
            D09639  Losmapimod (USAN/INN)
            D09661  Rintatolimod (USAN/INN)
            D10483  Peginterferon beta-1a (USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        7096  TLR1; toll like receptor 1 [KO:K05398]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            10333  TLR6; toll like receptor 6 [KO:K10169]
            3929  LBP; lipopolysaccharide binding protein [KO:K05399]
            929  CD14; CD14 molecule [KO:K04391]
            23643  LY96; lymphocyte antigen 96 [KO:K05400]
            7098  TLR3; toll like receptor 3 [KO:K05401]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            7100  TLR5; toll like receptor 5 [KO:K10168]
            51284  TLR7; toll like receptor 7 [KO:K05404]
            51311  TLR8; toll like receptor 8 [KO:K10170]
            1513  CTSK; cathepsin K [KO:K01371] [EC:3.4.22.38]
            54106  TLR9; toll like receptor 9 [KO:K10161]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            54472  TOLLIP; toll interacting protein [KO:K05402]
            4615  MYD88; myeloid differentiation primary response 88 [KO:K04729]
            114609  TIRAP; toll-interleukin 1 receptor (TIR) domain containing adaptor protein [KO:K05403]
            8772  FADD; Fas associated via death domain [KO:K02373]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            51135  IRAK4; interleukin 1 receptor associated kinase 4 [KO:K04733] [EC:2.7.11.1]
            3654  IRAK1; interleukin 1 receptor associated kinase 1 [KO:K04730] [EC:2.7.11.1]
            7189  TRAF6; TNF receptor associated factor 6 [KO:K03175] [EC:2.3.2.27]
            10454  TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1 [KO:K04403]
            23118  TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2 [KO:K04404]
            6885  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
            8517  IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO:K07210]
            1147  CHUK; conserved helix-loop-helix ubiquitous kinase [KO:K04467] [EC:2.7.11.10]
            3551  IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4790  NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
            5970  RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A [KO:K04735]
            1326  MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO:K04415] [EC:2.7.11.25]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5606  MAP2K3; mitogen-activated protein kinase kinase 3 [KO:K04432] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            3725  JUN; jun proto-oncogene [KO:K04448]
            2353  FOS; FBJ murine osteosarcoma viral oncogene homolog [KO:K04379]
            7124  TNF; tumor necrosis factor [KO:K03156]
            3553  IL1B; interleukin 1 beta [KO:K04519]
            3569  IL6; interleukin 6 [KO:K05405]
            3592  IL12A; interleukin 12A [KO:K05406]
            3593  IL12B; interleukin 12B [KO:K05425]
            3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]
            6352  CCL5; C-C motif chemokine ligand 5 [KO:K12499]
            6348  CCL3; C-C motif chemokine ligand 3 [KO:K05408]
            6349  CCL3L1; C-C motif chemokine ligand 3 like 1 [KO:K05408]
            414062  CCL3L3; C-C motif chemokine ligand 3 like 3 [KO:K05408]
            6351  CCL4; C-C motif chemokine ligand 4 [KO:K12964]
            9560  CCL4L2; chemokine (C-C motif) ligand 4-like 2 [KO:K12964]
            388372  CCL4L1; chemokine (C-C motif) ligand 4-like 1 [KO:K12964]
            353376  TICAM2; toll like receptor adaptor molecule 2 [KO:K05409]
            148022  TICAM1; toll like receptor adaptor molecule 1 [KO:K05842]
            8737  RIPK1; receptor interacting serine/threonine kinase 1 [KO:K02861] [EC:2.7.11.1]
            3663  IRF5; interferon regulatory factor 5 [KO:K09446]
            3665  IRF7; interferon regulatory factor 7 [KO:K09447]
            6696  SPP1; secreted phosphoprotein 1 [KO:K06250]
            9641  IKBKE; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon [KO:K07211] [EC:2.7.11.10]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            958  CD40; CD40 molecule [KO:K03160]
            941  CD80; CD80 molecule [KO:K05412]
            942  CD86; CD86 molecule [KO:K05413]
            3439  IFNA1; interferon, alpha 1 [KO:K05414]
            3440  IFNA2; interferon, alpha 2 [KO:K05414]
            3441  IFNA4; interferon, alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon, alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon, alpha 10 [KO:K05414]
            3447  IFNA13; interferon, alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon, alpha 16 [KO:K05414]
            3451  IFNA17; interferon, alpha 17 [KO:K05414]
            3452  IFNA21; interferon, alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            3627  CXCL10; C-X-C motif chemokine ligand 10 [KO:K12671]
            4283  CXCL9; C-X-C motif chemokine ligand 9 [KO:K05416]
            6373  CXCL11; C-X-C motif chemokine ligand 11 [KO:K12672]
REFERENCE   PMID:17275323
  AUTHORS   Kawai T, Akira S.
  TITLE     TLR signaling.
  JOURNAL   Semin Immunol 19:24-32 (2007)
REFERENCE   PMID:17457343
  AUTHORS   O'Neill LA, Bowie AG.
  TITLE     The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
  JOURNAL   Nat Rev Immunol 7:353-64 (2007)
REFERENCE   PMID:16932750
  AUTHORS   Honda K, Taniguchi T.
  TITLE     IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.
  JOURNAL   Nat Rev Immunol 6:644-58 (2006)
REFERENCE   PMID:17395581
  AUTHORS   Uematsu S, Akira S.
  TITLE     Toll-like receptors and Type I interferons.
  JOURNAL   J Biol Chem 282:15319-23 (2007)
REFERENCE   PMID:16497588
  AUTHORS   Akira S, Uematsu S, Takeuchi O.
  TITLE     Pathogen recognition and innate immunity.
  JOURNAL   Cell 124:783-801 (2006)
REFERENCE   PMID:14698224
  AUTHORS   Yamamoto M, Takeda K, Akira S.
  TITLE     TIR domain-containing adaptors define the specificity of TLR signaling.
  JOURNAL   Mol Immunol 40:861-8 (2004)
REFERENCE   
  AUTHORS   Matsumoto M, Oshiumi H, Seya T.
  TITLE     [TICAM-1, an adaptor molecule that participates in Toll-like receptor-mediated type1 interferon production.] (In Japanese)
  JOURNAL   Molecular Medicine 40:194-200 (2003)
REFERENCE   PMID:12734364
  AUTHORS   Means TK, Hayashi F, Smith KD, Aderem A, Luster AD.
  TITLE     The Toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells.
  JOURNAL   J Immunol 170:5165-75 (2003)
REFERENCE   PMID:14751764
  AUTHORS   Aderem A, Smith KD.
  TITLE     A systems approach to dissecting immunity and inflammation.
  JOURNAL   Semin Immunol 16:55-67 (2004)
REFERENCE   PMID:17637696
  AUTHORS   Banerjee A, Gerondakis S.
  TITLE     Coordinating TLR-activated signaling pathways in cells of the immune system.
  JOURNAL   Immunol Cell Biol : (2007)
REFERENCE   PMID:17507094
  AUTHORS   Loniewski KJ, Patial S, Parameswaran N.
  TITLE     Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
  JOURNAL   Mol Immunol 44:3715-23 (2007)
REFERENCE   PMID:11101877
  AUTHORS   Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG.
  TITLE     Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.
  JOURNAL   Nat Immunol 1:533-40 (2000)
REFERENCE   PMID:16924467
  AUTHORS   Uematsu S, Akira S.
  TITLE     Toll-like receptors and innate immunity.
  JOURNAL   J Mol Med 84:712-25 (2006)
KO_PATHWAY  ko04620
///
ENTRY       hsa04650                    Pathway
NAME        Natural killer cell mediated cytotoxicity - Homo sapiens (human)
DESCRIPTION Natural killer (NK) cells are lymphocytes of the innate immune system that are involved in early defenses against both allogeneic (nonself) cells and autologous cells undergoing various forms of stress, such as infection with viruses, bacteria, or parasites or malignant transformation. Although NK cells do not express classical antigen receptors of the immunoglobulin gene family, such as the antibodies produced by B cells or the T cell receptor expressed by T cells, they are equipped with various receptors whose engagement allows them to discriminate between target and nontarget cells. Activating receptors bind ligands on the target cell surface and trigger NK cell activation and target cell lysis. However Inhibitory receptors recognize MHC class I molecules (HLA) and inhibit killing by NK cells by overruling the actions of the activating receptors. This inhibitory signal is lost when the target cells do not express MHC class I and perhaps also in cells infected with virus, which might inhibit MHC class I exprssion or alter its conformation. The mechanism of NK cell killing is the same as that used by the cytotoxic T cells generated in an adaptive immune response; cytotoxic granules are released onto the surface of the bound target cell, and the effector proteins they contain penetrate the cell membrane and induce programmed cell death.
CLASS       Organismal Systems; Immune system
PATHWAY_MAP hsa04650  Natural killer cell mediated cytotoxicity
DISEASE     H00090  NK cell defects
            H00344  Leprosy
            H01018  Metachondromatosis
DRUG        D00745  Interferon alfa-2a (genetical recombination) (JAN)
            D00746  Interferon beta-1b (genetical recombination) (JAN)
            D00747  Interferon gamma-1b (USAN/INN)
            D02597  Adalimumab (genetical recombination) (JAN)
            D02744  Interferon alfacon-1 (genetical recombination) (JAN)
            D02745  Interferon alfa-2b (genetical recombination) (JAN)
            D02747  Peginterferon alfa-2a (genetical recombination) (JAN)
            D02748  Peginterferon alfa-2b (generical recombination) (JAN)
            D02811  Alicaforsen sodium (USAN)
            D03304  Interferon beta (JAN)
            D03305  Interferon alfa (NAMALWA) (JP17)
            D03357  Interferon gamma-1a (genetical recombination) (JAN)
            D03441  Certolizumab pegol (genetical recombination) (JAN)
            D03959  Efalizumab (USAN/INN)
            D04000  Enlimomab (USAN/INN)
            D04552  Interferon alfa-n1 (USAN)
            D04554  Interferon beta-1a (genetical recombination) (JAN)
            D06272  Sorafenib tosilate (JAN)
            D06611  Lexatumumab (USAN/INN)
            D08524  Sorafenib (USAN/INN)
            D08805  Interferon gamma-n1 (JAN)
            D08844  Albinterferon alfa-2b (USAN)
            D10483  Peginterferon beta-1a (USAN/INN)
            D10618  Defactinib (USAN/INN)
DBLINKS     BSID: 83079
            GO: 0042267
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3812  KIR3DL2; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2 [KO:K07980]
            3811  KIR3DL1; killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 [KO:K07980]
            3803  KIR2DL2; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2 [KO:K07981]
            3802  KIR2DL1; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 [KO:K07981]
            3804  KIR2DL3; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3 [KO:K07981]
            3805  KIR2DL4; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4 [KO:K07981]
            57292  KIR2DL5A; killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A [KO:K07981]
            3821  KLRC1; killer cell lectin like receptor C1 [KO:K06541]
            3822  KLRC2; killer cell lectin like receptor C2 [KO:K06541]
            3823  KLRC3; killer cell lectin like receptor C3 [KO:K06541]
            3824  KLRD1; killer cell lectin like receptor D1 [KO:K06516]
            5777  PTPN6; protein tyrosine phosphatase, non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
            5781  PTPN11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
            3384  ICAM2; intercellular adhesion molecule 2 [KO:K06523]
            3683  ITGAL; integrin subunit alpha L [KO:K05718]
            3689  ITGB2; integrin subunit beta 2 [KO:K06464]
            2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
            10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
            7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
            7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            5880  RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
            5881  RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO:K07861]
            5058  PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            7124  TNF; tumor necrosis factor [KO:K03156]
            1437  CSF2; colony stimulating factor 2 [KO:K05427]
            3458  IFNG; interferon, gamma [KO:K04687]
            3806  KIR2DS1; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1 [KO:K07982]
            3808  KIR2DS3; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 3 [KO:K07982]
            3809  KIR2DS4; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4 [KO:K07982]
            3810  KIR2DS5; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 5 [KO:K07982]
            100132285  KIR2DS2; killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 [KO:K07982]
            9436  NCR2; natural cytotoxicity triggering receptor 2 [KO:K06742]
            7305  TYROBP; TYRO protein tyrosine kinase binding protein [KO:K07992]
            3932  LCK; LCK proto-oncogene, Src family tyrosine kinase [KO:K05856] [EC:2.7.10.2]
            102723407  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8; K06856 immunoglobulin heavy chain [KO:K06856]
            2214  FCGR3A; Fc fragment of IgG receptor IIIa [KO:K06463]
            2215  FCGR3B; Fc fragment of IgG receptor IIIb [KO:K06463]
            9437  NCR1; natural cytotoxicity triggering receptor 1 [KO:K06741]
            259197  NCR3; natural cytotoxicity triggering receptor 3 [KO:K06743]
            2207  FCER1G; Fc fragment of IgE receptor Ig [KO:K07983]
            919  CD247; CD247 molecule [KO:K06453]
            7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70kDa [KO:K07360] [EC:2.7.10.2]
            6850  SYK; spleen tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            3937  LCP2; lymphocyte cytosolic protein 2 [KO:K07361]
            27040  LAT; linker for activation of T-cells [KO:K07362]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            6452  SH3BP2; SH3-domain binding protein 2 [KO:K07984]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            2534  FYN; FYN proto-oncogene, Src family tyrosine kinase [KO:K05703] [EC:2.7.10.2]
            6464  SHC1; SHC (Src homology 2 domain containing) transforming protein 1 [KO:K06279]
            25759  SHC2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K17447]
            53358  SHC3; SHC (Src homology 2 domain containing) transforming protein 3 [KO:K17448]
            399694  SHC4; SHC (Src homology 2 domain containing) family member 4 [KO:K17449]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            3265  HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
            3845  KRAS; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            4893  NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
            369  ARAF; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
            673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            4277  MICB; MHC class I polypeptide-related sequence B [KO:K07985]
            100507436  MICA; MHC class I polypeptide-related sequence A [KO:K07985]
            80329  ULBP1; UL16 binding protein 1 [KO:K07986]
            80328  ULBP2; UL16 binding protein 2 [KO:K07986]
            79465  ULBP3; UL16 binding protein 3 [KO:K07986]
            353091  RAET1G; retinoic acid early transcript 1G [KO:K07987]
            154064  RAET1L; retinoic acid early transcript 1L [KO:K07987]
            135250  RAET1E; retinoic acid early transcript 1E [KO:K07987]
            22914  KLRK1; killer cell lectin like receptor K1 [KO:K06728]
            100528032  KLRC4-KLRK1; KLRC4-KLRK1 readthrough [KO:K06728]
            10870  HCST; hematopoietic cell signal transducer [KO:K07988]
            962  CD48; CD48 molecule [KO:K06479]
            51744  CD244; CD244 molecule [KO:K06582]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            4772  NFATC1; nuclear factor of activated T-cells 1 [KO:K04446]
            4773  NFATC2; nuclear factor of activated T-cells 2 [KO:K17332]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            117157  SH2D1B; SH2 domain containing 1B [KO:K07989]
            4068  SH2D1A; SH2 domain containing 1A [KO:K07990]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            3460  IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) [KO:K05133]
            3439  IFNA1; interferon, alpha 1 [KO:K05414]
            3440  IFNA2; interferon, alpha 2 [KO:K05414]
            3441  IFNA4; interferon, alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon, alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon, alpha 10 [KO:K05414]
            3447  IFNA13; interferon, alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon, alpha 16 [KO:K05414]
            3451  IFNA17; interferon, alpha 17 [KO:K05414]
            3452  IFNA21; interferon, alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            8743  TNFSF10; tumor necrosis factor superfamily member 10 [KO:K04721]
            8797  TNFRSF10A; tumor necrosis factor receptor superfamily member 10a [KO:K04722]
            8795  TNFRSF10B; tumor necrosis factor receptor superfamily member 10b [KO:K04722]
            8794  TNFRSF10C; tumor necrosis factor receptor superfamily member 10c [KO:K04722]
            8793  TNFRSF10D; tumor necrosis factor receptor superfamily member 10d [KO:K04722]
            356  FASLG; Fas ligand [KO:K04389]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3002  GZMB; granzyme B [KO:K01353] [EC:3.4.21.79]
            5551  PRF1; perforin 1 [KO:K07818]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:15607802
  AUTHORS   Chiesa S, Tomasello E, Vivier E, Vely F.
  TITLE     Coordination of activating and inhibitory signals in natural killer cells.
  JOURNAL   Mol Immunol 42:477-84 (2005)
REFERENCE   PMID:16109839
  AUTHORS   Maghazachi AA.
  TITLE     Insights into seven and single transmembrane-spanning domain receptors and their signaling pathways in human natural killer cells.
  JOURNAL   Pharmacol Rev 57:339-57 (2005)
REFERENCE   PMID:15567854
  AUTHORS   Vivier E, Nunes JA, Vely F.
  TITLE     Natural killer cell signaling pathways.
  JOURNAL   Science 306:1517-9 (2004)
REFERENCE   PMID:12205470
  AUTHORS   Colucci F, Di Santo JP, Leibson PJ.
  TITLE     Natural killer cell activation in mice and men: different triggers for similar weapons?
  JOURNAL   Nat Immunol 3:807-13 (2002)
REFERENCE   PMID:11062493
  AUTHORS   Perussia B.
  TITLE     Signaling for cytotoxicity.
  JOURNAL   Nat Immunol 1:372-4 (2000)
REFERENCE   PMID:15607806
  AUTHORS   Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y.
  TITLE     Activation of NK cell cytotoxicity.
  JOURNAL   Mol Immunol 42:501-10 (2005)
REFERENCE   PMID:11895890
  AUTHORS   Djeu JY, Jiang K, Wei S.
  TITLE     A view to a kill: signals triggering cytotoxicity.
  JOURNAL   Clin Cancer Res 8:636-40 (2002)
REFERENCE   PMID:12530970
  AUTHORS   Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H.
  TITLE     Nature's TRAIL--on a path to cancer immunotherapy.
  JOURNAL   Immunity 18:1-6 (2003)
REFERENCE   PMID:16177799
  AUTHORS   Colonna M.
  TITLE     Fine-tuning NK cell responses: it's a family affair.
  JOURNAL   Nat Immunol 6:961-2 (2005)
REFERENCE   PMID:8942070
  AUTHORS   Bonnema JD, Leibson PJ.
  TITLE     Signal transduction during NK cell activation.
  JOURNAL   Chem Immunol 64:28-43 (1996)
REFERENCE   (Japanese)
  AUTHORS   Satoh T, Arase H.
  TITLE     [Recognition of virus infected cells by NK cell receptor.] (In Japanese)
  JOURNAL   Experimental Medicine 23(17):2685-2691 (2005)
REFERENCE   PMID:16002670
  AUTHORS   Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M.
  TITLE     Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.
  JOURNAL   J Immunol 175:749-54 (2005)
REFERENCE   PMID:9143705
  AUTHORS   Rao A, Luo C, Hogan PG.
  TITLE     Transcription factors of the NFAT family: regulation and function.
  JOURNAL   Annu Rev Immunol 15:707-47 (1997)
REFERENCE   PMID:14710949
  AUTHORS   Wu J, Lanier LL.
  TITLE     Natural killer cells and cancer.
  JOURNAL   Adv Cancer Res 90:127-56 (2003)
REFERENCE   PMID:11905813
  AUTHORS   Cerwenka A, Lanier LL.
  TITLE     Natural killer cells, viruses and cancer.
  JOURNAL   Nat Rev Immunol 1:41-9 (2001)
REFERENCE   PMID:11836514
  AUTHORS   Blott EJ, Griffiths GM.
  TITLE     Secretory lysosomes.
  JOURNAL   Nat Rev Mol Cell Biol 3:122-31 (2002)
REFERENCE   PMID:12766758
  AUTHORS   Lieberman J.
  TITLE     The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal.
  JOURNAL   Nat Rev Immunol 3:361-70 (2003)
REFERENCE   PMID:12752668
  AUTHORS   Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC.
  TITLE     Granzyme B: a natural born killer.
  JOURNAL   Immunol Rev 193:31-8 (2003)
REFERENCE   PMID:15618404
  AUTHORS   Liu D, Xu L, Yang F, Li D, Gong F, Xu T.
  TITLE     Rapid biogenesis and sensitization of secretory lysosomes in NK cells mediated by target-cell recognition.
  JOURNAL   Proc Natl Acad Sci U S A 102:123-7 (2005)
REFERENCE   PMID:9862693
  AUTHORS   Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.
  TITLE     Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.
  JOURNAL   J Immunol 161:6648-56 (1998)
REFERENCE   PMID:11390470
  AUTHORS   Jevremovic D, Billadeau DD, Schoon RA, Dick CJ, Leibson PJ.
  TITLE     Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
  JOURNAL   J Immunol 166:7219-28 (2001)
KO_PATHWAY  ko04650
///
